ProQR Announces Annual Meeting of Shareholders

LEIDEN, the Netherlands, April 07, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that the Annual General Meeting of Shareholders will be held on Tuesday, June 21, 2016 at 16:00 CET, at the offices of Allen & Overy at Apollolaan 15, 1077 AB Amsterdam, the Netherlands.

All relevant documents and information for the meeting, including the notice and agenda, are or will be made available in the ‘Investor Relations’ section of ProQR’s website (www.proqr.com) under ‘Financial Information’. The documents will also be made available on the SEC's website at www.sec.gov.

A live webcast of the event will be accessible in the ‘Investor Relations’ section of ProQR’s website under ‘Events and Presentations’.

About ProQR
ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe diseases such as cystic fibrosis and Leber’s congenital amaurosis. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind. Since 2012.

Contact:
Sariette Witte
Investor Relations
T: +1 213 261 8891
ir@proqr.com

You might like this

  • About ProQR Therapeutics

    ProQR was founded by Daniel de Boer with a mission to help people living with rare genetic diseases. This remains the main focus of our company today.

    Daniel de Boer wearing a blue suit stands with arm crossed in a laboratory setting.

  • Axiomer technology - RNA base editing

    A new way to use RNA oligonucleotides to alter RNA, discovered by ProQR. The Axiomer® technology enables the editing of specific single nucleotides in RNA using the cells own editing machinery.

    Axiomer RNA editing platform technology

  • Our science

    Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments for people with severe rare and common diseases.

    ProQR laboratory technicians